...
首页> 外文期刊>Acute and critical care. >Utility of Volume Assessment Using Bioelectrical Impedance Analysis in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective Observational Study
【24h】

Utility of Volume Assessment Using Bioelectrical Impedance Analysis in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective Observational Study

机译:应用生物电阻抗进行容量评估在接受连续性肾脏替代治疗的重症患者中的效用:一项前瞻性观察研究

获取原文
           

摘要

Background Fluid overload prior to continuous renal replacement therapy (CRRT) is an important prognostic factor. Thus, precise evaluation of fluid status is necessary to treat such patients. In this study, we investigated whether fluid assessment using bioelectrical impedance analysis (BIA) can predict outcomes in critically ill patients requiring CRRT. Methods A prospective observational study was performed in patients who were admitted to the intensive care unit and who required CRRT. BIA was conducted before CRRT; then, the ratio of extracellular water to total body water (ECW/TBW) was derived to estimate volume status. Results A total of 31 patients treated with CRRT were included. There were 18 men (58.1%), and the median age was 67 years (interquartile range, 51 to 78 years). Fourteen patients (45.2%) died within 28 days after CRRT initiation. Patients were divided into 16 with ECW/TBW ≥0.41 and 15 with ECW/TBW 0.41. Survival rate within 28 days was different between the two groups (P = 0.044). Cox regression analysis revealed a relationship between ECW/TBW ≥0.41 and 28-day mortality, but it was not statistically significant (hazard ratio, 3.0; 95% confidence interval, 0.9 to 9.8; P = 0.061). Lastly, the area under the curve of ECW/TBW for 28-day mortality was analyzed. The area under the curve of ECW/TBW was 0.73 (95% confidence interval, 0.54 to 0.92), and this was significant (P = 0.037). Conclusions Fluid status can be assessed using BIA in critically ill patients requiring CRRT, and BIA can predict mortality. Further large trials are needed to confirm the usefulness of BIA in critically ill patients.
机译:背景技术连续肾脏替代疗法(CRRT)之前的液体超负荷是重要的预后因素。因此,对液体状态的精确评估对于治疗此类患者是必要的。在这项研究中,我们调查了使用生物电阻抗分析(BIA)进行的液体评估是否可以预测需要CRRT的重症患者的预后。方法对入住重症监护室且需要CRRT的患者进行前瞻性观察研究。 BIA在CRRT之前进行;然后,得出细胞外水与人体总水的比例(ECW / TBW)以估计体积状态。结果共纳入31例接受CRRT治疗的患者。男性18位(58.1%),中位年龄为67岁(四分位间距为51至78岁)。 CRRT开始后28天内有14名患者(45.2%)死亡。将患者分为16例ECW / TBW≥0.41和15例ECW / TBW <0.41。两组在28天内的存活率有所不同(P = 0.044)。 Cox回归分析显示ECW / TBW≥0.41与28天死亡率之间存在相关性,但无统计学意义(危险比3.0; 95%置信区间0.9-9.8; P = 0.061)。最后,分析了ECW / TBW曲线下28天死亡率下的面积。 ECW / TBW曲线下的面积为0.73(95%置信区间为0.54至0.92),这是显着的(P = 0.037)。结论对于需要CRRT的危重患者,可以使用BIA评估体液状态,BIA可以预测死亡率。需要进一步的大型试验以确认BIA在危重患者中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号